Results 211 to 220 of about 5,284 (226)

Prevention of form‐deprivation myopia with pirenzepine: a study of drug delivery and distribution

Ophthalmic & physiological optics, 1999
C. Cottriall, Neville A. McBrien, R. Annies, E. M. Leech   +3 more
semanticscholar   +1 more source

The Intact Human Neuroblastoma Cell (SH‐SY5Y) Exhibits High‐Affinity [3H]Pirenzepine Binding Associated with Hydrolysis of Phosphatidylinositols

Journal of Neurochemistry, 1988
M. Serra, L. Mei, W. Roeske, G. Lui, M. Watson, H. Yamamura   +5 more
semanticscholar   +1 more source

Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia

, 2009
L. Nelson
semanticscholar   +1 more source

CHOLINERGIC MUSCARINIC RECEPTOR BLOCKADE WITH PIRENZEPINE ABOLISHES SLOW WAVE SLEEP‐RELATED GROWTH HORMONE RELEASE IN NORMAL ADULT MALES

Clinical Endocrinology, 1986
J. Peters, P. Evans, M. Page, R. Hall, J. T. Gibbs, C. Diéguez, M. Scanlon   +6 more
semanticscholar   +1 more source

A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.

Life Science, 1983
M. Watson, H. Yamamura, W. Roeske
semanticscholar   +1 more source

CHOLINERGIC MUSCARINIC RECEPTOR BLOCKADE WITH PIRENZEPINE ABOLISHES SLOW WAVE SLEEP‐RELATED GROWTH HORMONE RELEASE IN YOUNG PATIENTS WITH INSULIN‐DEPENDENT DIABETES MELLITUS

Clinical Endocrinology, 1987
M. Page, H. Koppeschaar, C. Diéguez, J. T. Gibbs, R. Hall, J. Peters, M. F. Scanlon   +6 more
semanticscholar   +1 more source

One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia.

Ophthalmology (Rochester, Minn.), 2004
D. Tan, D. Lam, W. Chua, Dorothy Fan Shu-Ping, R. Crockett   +4 more
semanticscholar   +1 more source

Mucosal protective agents: why forget pirenzepine?

Digestive Diseases and Sciences, 1988
openaire   +3 more sources

Levels of [3H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1

Schizophrenia Research, 2008
B. Dean, A. Soulby, G. Evin, E. Scarr
semanticscholar   +1 more source

Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.

Journal of Pharmacology and Experimental Therapeutics, 1985
D. Gil, B. Wolfe
semanticscholar   +1 more source